Formulation of Buprenorphine for Sublingual Use in Neonates

OBJECTIVES: The only medication used sublingually in the neonate is buprenorphine for the treatment of neonatal abstinence syndrome (NAS). Compared with morphine, buprenorphine reduces the length of treatment and length of hospitalization in neonates treated for NAS. The objective of this study was...

Full description

Saved in:
Bibliographic Details
Main Authors: Anagnostis, Ellena A., Sadaka, Rania E., Sailor, Linda A., Moody, David E., Dysart, Kevin C., Kraft, Walter K.
Format: Artigo
Language:Inglês
Published: Pediatric Pharmacy Advocacy Group 2011
Subjects:
Clinical Investigations
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3385042/
https://ncbi.nlm.nih.gov/pubmed/22768012
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-16.4.281
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items